INSERM, U1082, Ischémie-reperfusion en transplantation rénale, Université de Poitiers, Faculté de Médecine et de Pharmacie, Poitiers 86000, France.
J Transl Med. 2014 Mar 22;12:76. doi: 10.1186/1479-5876-12-76.
In kidney transplantation, the prevalence of hypercholesterolemia as a co-morbidity factor known to affect graft function, is rising due to the increased number of older donors in response to organ shortage as well as to the hyperlipidemic effects of immunosuppressors in recipient. This study aimed to characterize the effects of hypercholesterolemia on renal graft outcome, investigating the role of oxidized low-density lipoprotein (OxLDL).
In vivo, we used a porcine preclinical model of renal auto-transplantation modulated by two experimental diets: a normal (n = 6) or a hyperlipidemic diet (n = 5) maintained during the 3 month follow-up after the surgical procedure. Kidney function and OxLDL levels were monitored as well as fibrosis, LOX-1 and TGF beta signaling pathways. In vitro, we used human artery endothelial cells subjected to OxLDL to investigate the TGF beta profibrotic pathway and the role of the scavenger receptor LOX-1.
Hyperlipidemic diet-induced increase in plasma OxLDL levels at the time of surgery correlated with an increase in proteinuria 3 months after transplantation, associated with an early graft fibrosis combined with an activation of renal TGF beta signaling. These data suggest a direct involvement of OxLDL in the hyperlipidemic diet-induced activation of the pro-fibrotic TGF beta pathway which seems to be activated by LOX-1 signaling. These results were supported by studies with endothelial cells incubated in culture medium containing OxLDL promoting TGF beta expression inhibited by LOX-1 antibody.
These results implicate OxLDL in the hyperlipidemic diet-promoted fibrosis in transplanted kidneys, suggesting LOX-1 as a potential therapeutic target and reinforce the need to control cholesterol levels in kidney transplant recipients.
在肾移植中,由于器官短缺导致老年供体数量增加,以及免疫抑制剂对受者的脂质代谢影响,作为影响移植物功能的合并症因素,高胆固醇血症的患病率不断上升。本研究旨在探讨高胆固醇血症对肾移植预后的影响,并研究氧化型低密度脂蛋白(OxLDL)的作用。
在体内,我们使用了一种猪的肾自体移植的临床前模型,该模型通过两种实验饮食进行了调节:正常饮食(n = 6)或高脂饮食(n = 5),在手术后的 3 个月随访期间维持。监测了肾功能和 OxLDL 水平以及纤维化、LOX-1 和 TGFβ信号通路。在体外,我们使用人动脉内皮细胞进行 OxLDL 处理,以研究 TGFβ致纤维化途径和清道夫受体 LOX-1 的作用。
手术时高脂饮食诱导的血浆 OxLDL 水平升高与移植后 3 个月蛋白尿增加相关,与早期移植物纤维化有关,同时伴有肾 TGFβ信号的激活。这些数据表明,OxLDL 直接参与了高脂饮食诱导的致纤维化 TGFβ途径的激活,该途径似乎通过 LOX-1 信号被激活。内皮细胞在含有 OxLDL 的培养基中孵育的研究支持了这些结果,表明 OxLDL 促进 TGFβ表达,LOX-1 抗体可抑制 TGFβ表达。
这些结果表明,OxLDL 参与了高脂饮食促进的移植肾纤维化,提示 LOX-1 可能是一个潜在的治疗靶点,并强调了控制肾移植受者胆固醇水平的必要性。